Option Care Health, Inc. - Common Stock (OPCH)
Healthcare › Services-Home Health Care Services
Price History
Feb 9, 2026 — Apr 2, 2026Investment Snapshot
- Trading 68% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 15.3% — good return on equity
- Revenue growing at 13% annually
Option Care Health, Inc. - Common Stock (OPCH) is a Healthcare company operating in Services-Home Health Care Services, listed on the NASDAQ , with a market capitalisation of $4.1 billion . Key value metrics: P/E ratio 20.4, P/B ratio 3.12, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Option Care Health, Inc. - Common Stock — Fundamental Analysis Summary
Option Care Health, Inc. - Common Stock (OPCH) is currently trading 68% above its Graham Number of $15.73, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 20.4x.
On financial health, OPCH shows a moderate Piotroski F-Score of 5/9, and solid return on equity of 15.3% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.88.
StockPik's composite Value Score for OPCH is 63/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
OPCH reports a thin gross margin of 19.4% (sector average: 33.5%) and a modest operating margin of 6.1%.
OPCH shows revenue growing at 13% year-over-year, with earnings declining at 2%.